Return On Assets in % of Checkpoint Therapeutics, Inc. from Q2 2017 to Q1 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q2 2017 to Q1 2025.
  • Checkpoint Therapeutics, Inc. Return On Assets for the quarter ending 31 Mar 2025 was -431 %, a 42.6% increase year-over-year.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2024 was -743 %, a 21.8% increase from 2023.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2023 was -950 %, a 317% decline from 2022.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2022 was -228 %, a 146% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Checkpoint Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -431 +319 +42.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -743 +207 +21.8% 01 Oct 2024 31 Dec 2024
Q3 2024 -659 +63.7 +8.81% 01 Jul 2024 30 Sep 2024
Q2 2024 -673 -196 -41% 01 Apr 2024 30 Jun 2024
Q1 2024 -750 -441 -143% 01 Jan 2024 31 Mar 2024
Q4 2023 -950 -722 -317% 01 Oct 2023 31 Dec 2023
Q3 2023 -723 -535 -286% 01 Jul 2023 30 Sep 2023
Q2 2023 -477 -327 -218% 01 Apr 2023 30 Jun 2023
Q1 2023 -309 -190 -160% 01 Jan 2023 31 Mar 2023
Q4 2022 -228 -135 -146% 01 Oct 2022 31 Dec 2022
Q3 2022 -187 -123 -191% 01 Jul 2022 30 Sep 2022
Q2 2022 -150 -92.4 -160% 01 Apr 2022 30 Jun 2022
Q1 2022 -119 -56.6 -91.1% 01 Jan 2022 31 Mar 2022
Q4 2021 -92.8 -22.4 -31.8% 01 Oct 2021 31 Dec 2021
Q3 2021 -64.3 +10.8 +14.4% 01 Jul 2021 30 Sep 2021
Q2 2021 -57.9 +43.1 +42.7% 01 Apr 2021 30 Jun 2021
Q1 2021 -62.1 +49.1 +44.2% 01 Jan 2021 31 Mar 2021
Q4 2020 -70.4 +67.7 +49% 01 Oct 2020 31 Dec 2020
Q3 2020 -75.1 +83.3 +52.6% 01 Jul 2020 30 Sep 2020
Q2 2020 -101 +45.8 +31.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -111 +22.8 +17% 01 Jan 2020 31 Mar 2020
Q4 2019 -138 -18 -15% 01 Oct 2019 31 Dec 2019
Q3 2019 -158 -54 -51.8% 01 Jul 2019 30 Sep 2019
Q2 2019 -147 -49.9 -51.5% 01 Apr 2019 30 Jun 2019
Q1 2019 -134 -37.8 -39.2% 01 Jan 2019 31 Mar 2019
Q4 2018 -120 -37.1 -44.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -104 -23.3 -28.7% 01 Jul 2018 30 Sep 2018
Q2 2018 -96.9 -26.6 -37.8% 01 Apr 2018 30 Jun 2018
Q1 2018 -96.3 01 Jan 2018 31 Mar 2018
Q4 2017 -83.1 01 Oct 2017 31 Dec 2017
Q3 2017 -81.1 01 Jul 2017 30 Sep 2017
Q2 2017 -70.3 01 Apr 2017 30 Jun 2017

Checkpoint Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -743 +207 +21.8% 01 Jan 2024 31 Dec 2024
2023 -950 -722 -317% 01 Jan 2023 31 Dec 2023
2022 -228 -135 -146% 01 Jan 2022 31 Dec 2022
2021 -92.8 -22.4 -31.8% 01 Jan 2021 31 Dec 2021
2020 -70.4 +67.7 +49% 01 Jan 2020 31 Dec 2020
2019 -138 -18 -15% 01 Jan 2019 31 Dec 2019
2018 -120 -37.1 -44.7% 01 Jan 2018 31 Dec 2018
2017 -83.1 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.